ACHC
Income statement / Annual
Last year (2023), Acadia Healthcare Company, Inc.'s total revenue was $2.93 B,
an increase of 12.20% from the previous year.
In 2023, Acadia Healthcare Company, Inc.'s net income was -$21.67 M.
See Acadia Healthcare Company, Inc.’s key income statements, including revenue, expenses, profit, and income.
Period |
FY-2023
|
FY-2022
|
FY-2021
|
FY-2020
|
FY-2019
|
FY-2018
|
FY-2017
|
FY-2016
|
FY-2015
|
FY-2014
|
Period Ended |
12/31/2023 |
12/31/2022 |
12/31/2021 |
12/31/2020 |
12/31/2019 |
12/31/2018 |
12/31/2017 |
12/31/2016 |
12/31/2015 |
12/31/2014 |
Operating Revenue |
$2.93 B
|
$2.61 B
|
$2.31 B
|
$2.09 B
|
$3.11 B
|
$3.01 B
|
$2.84 B
|
$2.81 B
|
$1.79 B
|
$1.00 B
|
Cost of Revenue |
$2.25 B |
$1.49 B |
$1.33 B |
$1.24 B |
$1.84 B |
$1.78 B |
$1.65 B |
$1.66 B |
$1.05 B |
$623.83 M |
Gross Profit |
$682.61 M |
$1.12 B |
$979.89 M |
$848.17 M |
$1.27 B |
$1.23 B |
$1.19 B |
$1.15 B |
$740.10 M |
$380.77 M |
Gross Profit Ratio |
0.23 |
0.43 |
0.42 |
0.41 |
0.41 |
0.41 |
0.42 |
0.41 |
0.41 |
0.38 |
Research and Development
Expenses |
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
General & Administrative
Expenses |
$176.01 M
|
$203.48 M
|
$175.26 M
|
$157.85 M
|
$323.21 M
|
$307.71 M
|
$273.00 M
|
$258.83 M
|
$148.99 M
|
$64.68 M
|
Selling & Marketing
Expenses |
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
Selling, General &
Administrative Expenses |
$176.01 M
|
$203.48 M
|
$175.26 M
|
$157.85 M
|
$323.21 M
|
$307.71 M
|
$273.00 M
|
$258.83 M
|
$148.99 M
|
$64.68 M
|
Other Expenses |
$0.00 |
$445.60 M |
$390.16 M |
$357.53 M |
$539.48 M |
-$34.51 M |
-$24.27 M |
-$48.32 M |
-$36.57 M |
-$13.65 M |
Operating Expenses |
$176.01 M |
$649.07 M |
$565.41 M |
$515.38 M |
$862.69 M |
$821.04 M |
$747.84 M |
$706.49 M |
$419.29 M |
$208.00 M |
Cost And Expenses |
$2.42 B |
$2.14 B |
$1.90 B |
$1.76 B |
$2.70 B |
$2.60 B |
$2.40 B |
$2.37 B |
$1.47 B |
$831.84 M |
Interest Income |
$0.00 |
$69.76 M |
$76.99 M |
$158.11 M |
$187.33 M |
$876,000.00 |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
Interest Expense |
$82.13 M |
$69.76 M |
$76.99 M |
$158.11 M |
$187.09 M |
$185.41 M |
$176.01 M |
$181.33 M |
$106.74 M |
$48.22 M |
Depreciation &
Amortization |
$132.35 M
|
$117.77 M
|
$106.72 M
|
$95.26 M
|
$87.92 M
|
$158.83 M
|
$143.01 M
|
$135.10 M
|
$63.55 M
|
$32.67 M
|
EBITDA |
$189.11 M
|
$561.67 M
|
$459.47 M
|
$437.16 M
|
$402.02 M
|
$385.88 M
|
$580.89 M
|
$580.25 M
|
$384.36 M
|
$205.43 M
|
EBITDA Ratio |
0.06 |
0.22 |
0.23 |
0.22 |
0.18 |
0.19 |
0.2 |
0.21 |
0.21 |
0.2 |
Operating Income Ratio
|
0.17
|
0.17
|
0.18
|
0.17
|
0.13
|
0.14
|
0.15
|
0.16
|
0.18
|
0.17
|
Total Other
Income/Expenses Net |
-$531.96 M
|
-$72.10 M
|
-$120.81 M
|
-$148.99 M
|
-$235.70 M
|
-$581.70 M
|
-$201.08 M
|
-$412.19 M
|
-$156.06 M
|
-$46.61 M
|
Income Before Tax |
-$25.36 M |
$374.14 M |
$275.76 M |
$183.80 M |
$135.99 M |
-$168.95 M |
$236.80 M |
$32.96 M |
$164.75 M |
$126.15 M |
Income Before Tax Ratio
|
-0.01
|
0.14
|
0.12
|
0.09
|
0.04
|
-0.06
|
0.08
|
0.01
|
0.09
|
0.13
|
Income Tax Expense |
-$9.70 M |
$94.11 M |
$67.56 M |
$40.61 M |
$25.87 M |
$6.53 M |
$37.21 M |
$28.78 M |
$46.40 M |
$42.92 M |
Net Income |
-$21.67 M |
$273.14 M |
$190.64 M |
$143.19 M |
$108.92 M |
-$175.75 M |
$199.84 M |
$6.14 M |
$119.55 M |
$83.04 M |
Net Income Ratio |
-0.01 |
0.1 |
0.08 |
0.07 |
0.04 |
-0.06 |
0.07 |
0 |
0.07 |
0.08 |
EPS |
-0.24 |
3.05 |
2.3 |
1.63 |
1.24 |
-2.01 |
2.3 |
0.07 |
1.75 |
1.51 |
EPS Diluted |
-0.24 |
2.98 |
2.25 |
1.62 |
1.24 |
-2.01 |
2.3 |
0.07 |
1.75 |
1.5 |
Weighted Average Shares
Out |
$90.95 M
|
$89.68 M
|
$88.77 M
|
$87.88 M
|
$87.61 M
|
$87.29 M
|
$86.95 M
|
$85.70 M
|
$68.09 M
|
$55.06 M
|
Weighted Average Shares
Out Diluted |
$90.95 M
|
$91.56 M
|
$90.79 M
|
$88.60 M
|
$87.82 M
|
$87.29 M
|
$87.06 M
|
$85.97 M
|
$68.39 M
|
$55.33 M
|
Link |
|
|
|
|
|
|
|
|
|
|